ArticleEndocrine-related cancer2021

Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers.

Kathleen A Luckett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.